N/A
N=45
Prevention of Early Postoperative Decline
Delirium · Postoperative Cognitive Dysfunction
Bottom Line
View on ClinicalTrials.gov: NCT02908464 ↗Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Jun 2020
Primary outcome: Primary: Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Enrollment — 45 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lumosity (Device)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Beth Israel Deaconess Medical Center
- Primary completion
- Jan 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Enrollment |
45 | — |
| PRIMARY Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Adherence |
39; 0; 6; 0; 19; 0 | — |
| SECONDARY Number of Participants With Postoperative Delirium Measured by the Confusion Assessment Method (CAM) |
5; 3; 15; 17 | — |
| SECONDARY Number of Participants With Postoperative Cognitive Decline |
9; 7; 8; 12 | — |
| SECONDARY Postoperative Cognitive Dysfunction Measured Using the Montreal Cognitive Assessment (MoCA) |
20.0; 19.0; 20.0; 21.0; 20.0; 20.5 | — |
Summary
The purpose of this trial is to determine whether using a brain training program in the time leading up to as well as after heart surgery will reduce confusion and cognitive loss that can occur after surgery.
Eligibility Criteria
Inclusion Criteria
- Adult patients undergoing cardiac surgery age 60-90
- Cardiac surgery scheduled at least 10 days from enrollment
- High school education level or equivalent
Exclusion Criteria
- Preexisting psychiatric illness
- History of cerebrovascular event or seizure
- Non English speakers
- Baseline severe cognitive dysfunction including Alzheimer's, Parkinson's, or other severe forms of dementia
- Significant visual impairment
- Enrollment in another study involving cognition
Data sourced from ClinicalTrials.gov (NCT02908464). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.